Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
NeuroBo Pharmaceuticals ( (NRBO) ) just unveiled an update.
NeuroBo Pharmaceuticals is set to rebrand as MetaVia Inc. on November 29, 2024, with a new Nasdaq ticker symbol, MTVA, reflecting its focus on cardiometabolic diseases. This strategic realignment accompanies significant clinical milestones, including trials for DA-1241 and DA-1726, targeting conditions like obesity and MASH. Despite the name change, shareholders’ rights remain unaffected, and operations continue as usual, supported by a strong financing background.
Learn more about NRBO stock on TipRanks’ Stock Analysis page.
Trending Articles
- Shareholder Alert for iLearningEngines Holdings (NASDAQ:AILE)
- 3 Penny Stocks to Watch Now, 11/19/24
- Class Action Lawsuit Against Metagenomi Inc. (NASDAQ:MGX)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
